Growth Metrics

Enanta Pharmaceuticals (ENTA) EBT (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.82%
Dec 31, 2025 36.18%
Sep 30, 2025 -2.43%
Jun 30, 2025 23.90%
Mar 31, 2025 -5.47%
Dec 31, 2024 22.20%
Sep 30, 2024 -26.60%
Jun 30, 2024 26.86%
Mar 31, 2024 7.37%
Dec 31, 2023 -15.29%
Sep 30, 2023 15.29%
Jun 30, 2023 7.36%
Mar 31, 2023 -29.61%
Dec 31, 2022 -10.20%
Sep 30, 2022 18.08%
Jun 30, 2022 4.30%
Mar 31, 2022 -11.41%
Dec 31, 2021 9.71%
Sep 30, 2021 0.04%
Jun 30, 2021 -14.59%
Mar 31, 2021 -150.86%
Dec 31, 2020 37.63%
Sep 30, 2020 12.95%
Jun 30, 2020 -115.69%
Mar 31, 2020 -166.40%
Dec 31, 2019 71.71%
Sep 30, 2019 41.09%
Jun 30, 2019 555.69%
Mar 31, 2019 -96.84%
Dec 31, 2018 -17.11%
Sep 30, 2018 49.64%
Jun 30, 2018 33.77%
Mar 31, 2018 16.87%
Dec 31, 2017 -72.09%
Sep 30, 2017 538.62%
Jun 30, 2017 -39.88%
Mar 31, 2017 -37.34%
Dec 31, 2016 -148.17%
Sep 30, 2016 -309.35%
Jun 30, 2016 -590.32%
Mar 31, 2016 -100.26%
Dec 31, 2015 758.79%
Sep 30, 2015 110.20%
Jun 30, 2015 -95.92%
Mar 31, 2015 -30.83%
Dec 31, 2014 1,485.28%
Sep 30, 2014 -114.57%
Jun 30, 2014 771.36%
Mar 31, 2014 3.11%
Dec 31, 2013 -20.86%
Sep 30, 2013 -7.37%
Jun 30, 2013 -4.42%
Mar 31, 2013 -118.07%
Dec 31, 2012 640.99%
Sep 30, 2012 -16.52%
Jun 30, 2012 -110.84%